Proto Labs, Inc.

Valuation Analysis

About the Company

Proto Labs, Inc. en bref

Proto Labs, Inc. (PRLB) is currently trading at 70,74 € with a market capitalization of 1,7 Md €. The trailing P/E ratio stands at 76.47x, with a forward P/E of 36.72x. The 52-week range spans from 33,08 € to 72,56 €; the current price is 2.5% below the yearly high. Year-over-year revenue growth stands at +10.4%. The net profit margin stands at 4.71%.

💰 Dividende

Proto Labs, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Proto Labs, Inc. (PRLB) au consensus : Acheter. L'objectif de cours moyen est de 70,69 €, soit un potentiel de -0.07% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 61,09 € à 79,41 €.

Proto Labs, Inc. : la thèse d'investissement en détail

Proto Labs, Inc. (PRLB) operates in the Industrials — specifically Metal Fabrication — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 10.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 121.3% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

With a net margin of just 4.71%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

With a PEG ratio of 0.86, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 26.17x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

• The forward P/E of 36.72x is meaningfully below the trailing 76.47x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 95.4% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to market-like volatility.

Trading Data

Related Stocks in the Same Sector

Where can I buy Proto Labs, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.